secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImmunityBio, Inc. (IBRX)
CIK:        0001326110
Form:       8-K
Filed at:   2025-04-08T23:59:59+00:00
Accession:  0001193125-25-075102
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ImmunityBio raises $75M in registered direct offering of common stock and warrants
--------------------------------------------------------------------------------

- Gross proceeds of ~$75M from sale of 29.0M shares and warrants; warrants exercisable at $3.101 for 5 years.
- Offering priced at $2.584 per share plus warrant; expected close April 9, 2025.
- If fully exercised, warrants could yield additional ~$90M in gross proceeds.
- Single institutional investor; securities offered under existing shelf registration.
- Use of proceeds: working capital and support ongoing business operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326110/000119312525075102/0001193125-25-075102-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326110/000119312525075102/d943675d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-075102

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer